How much is the world spending on neglected disease research and development?
The first comprehensive survey of global spending on neglected disease R&D, published in this week’s PLoS Medicine, finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseases—HIV/AIDS, TB, and malaria—receiving nearly 80% of the total.However, the survey finds that many neglected diseases, responsible for killing millions of people in developing countries, are significantly underfunded.Researchers from The George Institute report that while HIV/AIDS, TB and malaria collectively received the majority of R&D funding, other diseases and disease categories each received less than 5% of global funding. ADVERTISEMENT &ct0=INSERT_CLICKURL_HERE” framespacing=”0″ frameborder=”no” scrolling=”no” width=”300″ height=”250″>” target=”_blank”>&n=a30c42f2&ct0=INSERT_CLICKURL_HERE” border=”0″ alt=””> Sleeping sickness, leishmaniasis and Chagas disease collectively received only 4.9% of total global funding; the diarrhoeal illnesses surveyed collectively rece
